Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Prepaid Assets: 2022-2024

Historic Prepaid Assets for Day One Biopharmaceuticals (DAWN) over the last 3 years, with Dec 2024 value amounting to $13.4 million.

  • Day One Biopharmaceuticals' Prepaid Assets rose 30.85% to $14.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.6 million, marking a year-over-year increase of 30.85%. This contributed to the annual value of $13.4 million for FY2024, which is 50.25% up from last year.
  • Per Day One Biopharmaceuticals' latest filing, its Prepaid Assets stood at $13.4 million for FY2024, which was up 50.25% from $8.9 million recorded in FY2023.
  • In the past 5 years, Day One Biopharmaceuticals' Prepaid Assets registered a high of $13.4 million during FY2024, and its lowest value of $5.6 million during FY2022.
  • For the 3-year period, Day One Biopharmaceuticals' Prepaid Assets averaged around $9.3 million, with its median value being $8.9 million (2023).
  • Data for Day One Biopharmaceuticals' Prepaid Assets shows a peak YoY skyrocketed of 59.27% (in 2023) over the last 5 years.
  • Over the past 3 years, Day One Biopharmaceuticals' Prepaid Assets (Yearly) stood at $5.6 million in 2022, then surged by 59.27% to $8.9 million in 2023, then soared by 50.25% to $13.4 million in 2024.